Work

Abstract CT247: FORTE: A phase 2 master protocol assessing plixorafenib for BRAF-altered cancers

Year: 2025

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2025-ct247

Authors: Karisa C. Schreck, Macarena I. de la Fuente, Jessica Rine, Irina Kline, Stacie Peacock Shepherd, Jordi Rodon, Rona Yaeger, Eric Sherman

Institutions: Johns Hopkins University, University of Miami, The University of Texas MD Anderson Cancer Center, Memorial Sloan Kettering Cancer Center

Language: English

Topic: Melanoma and MAPK Pathways

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4409821593

Cites:

Cited by: 2

Related to: 10